70639-82-6 Usage
Uses
Used in Medicinal Chemistry:
6-(2-BROMO-ACETYL)-3,4-DIHYDRO-1H-QUINOLIN-2-ONE is used as a synthetic intermediate for the development of new pharmaceutical compounds. Its unique structure allows for the creation of derivatives that can be tested for potential therapeutic effects.
Used in Chemical Synthesis:
In the field of organic chemistry, 6-(2-BROMO-ACETYL)-3,4-DIHYDRO-1H-QUINOLIN-2-ONE serves as a valuable starting material for the synthesis of more complex molecules. Its bromoacetyl group can be used in various reaction pathways, such as coupling reactions, to produce a wide range of chemical products.
Used in Research and Development:
6-(2-BROMO-ACETYL)-3,4-DIHYDRO-1H-QUINOLIN-2-ONE is utilized in academic and industrial research settings to explore its chemical properties and potential applications. Its reactivity and the possibility of modifying its structure make it an interesting subject for scientific investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 70639-82-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,6,3 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70639-82:
(7*7)+(6*0)+(5*6)+(4*3)+(3*9)+(2*8)+(1*2)=136
136 % 10 = 6
So 70639-82-6 is a valid CAS Registry Number.
InChI:InChI=1/C11H10BrNO2/c12-6-10(14)8-1-3-9-7(5-8)2-4-11(15)13-9/h1,3,5H,2,4,6H2,(H,13,15)
70639-82-6Relevant academic research and scientific papers
Cyclic keto-pyridone-linked heteroaromatic ring compound as well as preparation method and application thereof
-
Paragraph 0121; 0123-0125, (2021/05/12)
The invention belongs to the field of medicinal chemistry, specifically, the invention relates to a cyclic ketone and pyridone hetero-aromatic ring compound as well as a preparation method and an application of the cyclic ketone and pyridone hetero-aromatic ring compound. The structure of the compound is shown as a general formula (I). The compounds or the stereoisomers, racemes, geometric isomers, tautomers, prodrugs, hydrates, solvates or pharmaceutically acceptable salts and pharmaceutical compositions thereof can be used for treating or/and preventing related diseases mediated by the FXIa (Factor XIa for short).
